| UniProt ID | ARFG2_HUMAN | |
|---|---|---|
| UniProt AC | Q8N6H7 | |
| Protein Name | ADP-ribosylation factor GTPase-activating protein 2 | |
| Gene Name | ARFGAP2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 521 | |
| Subcellular Localization |
Cytoplasm . Golgi apparatus membrane Peripheral membrane protein Cytoplasmic side . Also found on peripheral punctate structures likely to be endoplasmic reticulum-Golgi intermediate compartment. |
|
| Protein Description | GTPase-activating protein (GAP) for ADP ribosylation factor 1 (ARF1). Implicated in coatomer-mediated protein transport between the Golgi complex and the endoplasmic reticulum. Hydrolysis of ARF1-bound GTP may lead to dissociation of coatomer from Golgi-derived membranes to allow fusion with target membranes.. | |
| Protein Sequence | MAAEPNKTEIQTLFKRLRAVPTNKACFDCGAKNPSWASITYGVFLCIDCSGVHRSLGVHLSFIRSTELDSNWNWFQLRCMQVGGNANATAFFRQHGCTANDANTKYNSRAAQMYREKIRQLGSAALARHGTDLWIDNMSSAVPNHSPEKKDSDFFTEHTQPPAWDAPATEPSGTQQPAPSTESSGLAQPEHGPNTDLLGTSPKASLELKSSIIGKKKPAAAKKGLGAKKGLGAQKVSSQSFSEIERQAQVAEKLREQQAADAKKQAEESMVASMRLAYQELQIDRKKEEKKLQNLEGKKREQAERLGMGLVSRSSVSHSVLSEMQVIEQETPVSAKSSRSQLDLFDDVGTFASGPPKYKDNPFSLGESFGSRWDTDAAWGMDRVEEKEPEVTISSIRPISERATNRREVESRSSGLESSEARQKFAGAKAISSDMFFGREVDAEYEARSRLQQLSGSSAISSSDLFGDMDGAHGAGSVSLGNVLPTADIAQFKQGVKSVAGKMAVLANGVMNSLQDRYGSY | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAAEPNKTE ------CCCCCCHHH | 22.11 | 22814378 | |
| 7 | Ubiquitination | -MAAEPNKTEIQTLF -CCCCCCHHHHHHHH | 59.24 | - | |
| 8 | Phosphorylation | MAAEPNKTEIQTLFK CCCCCCHHHHHHHHH | 44.98 | 20068231 | |
| 15 | Ubiquitination | TEIQTLFKRLRAVPT HHHHHHHHHHCCCCC | 54.35 | - | |
| 24 | Malonylation | LRAVPTNKACFDCGA HCCCCCCCCHHHCCC | 49.35 | 26320211 | |
| 24 | Ubiquitination | LRAVPTNKACFDCGA HCCCCCCCCHHHCCC | 49.35 | - | |
| 88 (in isoform 2) | Phosphorylation | - | 9.63 | 28348404 | |
| 93 (in isoform 2) | Phosphorylation | - | 22.57 | 28348404 | |
| 94 (in isoform 2) | Phosphorylation | - | 31.97 | 28348404 | |
| 102 | Ubiquitination | HGCTANDANTKYNSR CCCCCHHHCHHHHHH | 25.96 | - | |
| 105 | Ubiquitination | TANDANTKYNSRAAQ CCHHHCHHHHHHHHH | 42.09 | - | |
| 123 | Phosphorylation | EKIRQLGSAALARHG HHHHHHHHHHHHHHC | 20.97 | - | |
| 131 | Phosphorylation | AALARHGTDLWIDNM HHHHHHCCCEEEECC | 23.07 | 23927012 | |
| 139 | Phosphorylation | DLWIDNMSSAVPNHS CEEEECCCCCCCCCC | 22.77 | 22167270 | |
| 140 | Phosphorylation | LWIDNMSSAVPNHSP EEEECCCCCCCCCCC | 23.63 | 22167270 | |
| 146 | Phosphorylation | SSAVPNHSPEKKDSD CCCCCCCCCCCCCCC | 41.20 | 22167270 | |
| 152 | Phosphorylation | HSPEKKDSDFFTEHT CCCCCCCCCCCCCCC | 45.24 | 26074081 | |
| 156 | Phosphorylation | KKDSDFFTEHTQPPA CCCCCCCCCCCCCCC | 27.18 | 21406692 | |
| 159 | Phosphorylation | SDFFTEHTQPPAWDA CCCCCCCCCCCCCCC | 36.22 | 21406692 | |
| 169 | Phosphorylation | PAWDAPATEPSGTQQ CCCCCCCCCCCCCCC | 47.58 | 21406692 | |
| 172 | Phosphorylation | DAPATEPSGTQQPAP CCCCCCCCCCCCCCC | 48.52 | 21406692 | |
| 174 | Phosphorylation | PATEPSGTQQPAPST CCCCCCCCCCCCCCC | 28.50 | 21406692 | |
| 180 | Phosphorylation | GTQQPAPSTESSGLA CCCCCCCCCCCCCCC | 47.08 | 18669648 | |
| 181 | Phosphorylation | TQQPAPSTESSGLAQ CCCCCCCCCCCCCCC | 38.54 | 21406692 | |
| 183 | Phosphorylation | QPAPSTESSGLAQPE CCCCCCCCCCCCCCC | 29.78 | 26074081 | |
| 184 | Phosphorylation | PAPSTESSGLAQPEH CCCCCCCCCCCCCCC | 31.43 | 26074081 | |
| 191 | Acetylation | SGLAQPEHGPNTDLL CCCCCCCCCCCCCCC | 64.79 | - | |
| 195 | Phosphorylation | QPEHGPNTDLLGTSP CCCCCCCCCCCCCCC | 31.02 | 30576142 | |
| 200 | Phosphorylation | PNTDLLGTSPKASLE CCCCCCCCCCCHHHH | 41.65 | 26074081 | |
| 201 | Phosphorylation | NTDLLGTSPKASLEL CCCCCCCCCCHHHHH | 23.70 | 28348404 | |
| 205 | Phosphorylation | LGTSPKASLELKSSI CCCCCCHHHHHHHHH | 28.62 | 23403867 | |
| 209 | Ubiquitination | PKASLELKSSIIGKK CCHHHHHHHHHCCCC | 32.55 | - | |
| 210 | Phosphorylation | KASLELKSSIIGKKK CHHHHHHHHHCCCCC | 39.12 | 23403867 | |
| 211 | Phosphorylation | ASLELKSSIIGKKKP HHHHHHHHHCCCCCH | 19.35 | 23403867 | |
| 215 | Acetylation | LKSSIIGKKKPAAAK HHHHHCCCCCHHHHH | 47.41 | 25953088 | |
| 215 | Ubiquitination | LKSSIIGKKKPAAAK HHHHHCCCCCHHHHH | 47.41 | - | |
| 222 | Acetylation | KKKPAAAKKGLGAKK CCCHHHHHHCCCCCC | 42.52 | 7975635 | |
| 223 | Acetylation | KKPAAAKKGLGAKKG CCHHHHHHCCCCCCC | 55.42 | 7975645 | |
| 228 | Acetylation | AKKGLGAKKGLGAQK HHHCCCCCCCCCCCC | 45.64 | 7975655 | |
| 229 | Ubiquitination | KKGLGAKKGLGAQKV HHCCCCCCCCCCCCC | 59.85 | - | |
| 235 | Ubiquitination | KKGLGAQKVSSQSFS CCCCCCCCCCCCCHH | 43.48 | - | |
| 237 | Phosphorylation | GLGAQKVSSQSFSEI CCCCCCCCCCCHHHH | 29.69 | 23401153 | |
| 238 | Phosphorylation | LGAQKVSSQSFSEIE CCCCCCCCCCHHHHH | 32.60 | 25072903 | |
| 240 | Phosphorylation | AQKVSSQSFSEIERQ CCCCCCCCHHHHHHH | 32.46 | 29255136 | |
| 242 | Phosphorylation | KVSSQSFSEIERQAQ CCCCCCHHHHHHHHH | 42.80 | 29255136 | |
| 250 | Ubiquitination | EIERQAQVAEKLREQ HHHHHHHHHHHHHHH | 9.23 | - | |
| 252 | Ubiquitination | ERQAQVAEKLREQQA HHHHHHHHHHHHHHH | 54.49 | - | |
| 253 | Acetylation | RQAQVAEKLREQQAA HHHHHHHHHHHHHHH | 43.01 | 25953088 | |
| 253 | Ubiquitination | RQAQVAEKLREQQAA HHHHHHHHHHHHHHH | 43.01 | - | |
| 269 | Phosphorylation | AKKQAEESMVASMRL HHHHHHHHHHHHHHH | 15.29 | 28555341 | |
| 270 | Sulfoxidation | KKQAEESMVASMRLA HHHHHHHHHHHHHHH | 3.10 | 21406390 | |
| 273 | Phosphorylation | AEESMVASMRLAYQE HHHHHHHHHHHHHHH | 7.94 | 28857561 | |
| 278 | Phosphorylation | VASMRLAYQELQIDR HHHHHHHHHHHHCCH | 13.70 | 21945579 | |
| 290 | Ubiquitination | IDRKKEEKKLQNLEG CCHHHHHHHHHHCCC | 60.93 | 21890473 | |
| 291 | Ubiquitination | DRKKEEKKLQNLEGK CHHHHHHHHHHCCCH | 59.59 | - | |
| 298 | Acetylation | KLQNLEGKKREQAER HHHHCCCHHHHHHHH | 39.00 | 23749302 | |
| 298 | Ubiquitination | KLQNLEGKKREQAER HHHHCCCHHHHHHHH | 39.00 | - | |
| 308 | Sulfoxidation | EQAERLGMGLVSRSS HHHHHHCCCCCCHHH | 4.43 | 21406390 | |
| 312 | Phosphorylation | RLGMGLVSRSSVSHS HHCCCCCCHHHCCHH | 31.33 | 23186163 | |
| 314 | Phosphorylation | GMGLVSRSSVSHSVL CCCCCCHHHCCHHHH | 27.82 | 23401153 | |
| 315 | Phosphorylation | MGLVSRSSVSHSVLS CCCCCHHHCCHHHHH | 26.91 | 21712546 | |
| 317 | Phosphorylation | LVSRSSVSHSVLSEM CCCHHHCCHHHHHHC | 16.40 | 21712546 | |
| 319 | Phosphorylation | SRSSVSHSVLSEMQV CHHHCCHHHHHHCEE | 19.76 | 21712546 | |
| 322 | Ubiquitination | SVSHSVLSEMQVIEQ HCCHHHHHHCEEEEE | 28.94 | 21890473 | |
| 322 | Phosphorylation | SVSHSVLSEMQVIEQ HCCHHHHHHCEEEEE | 28.94 | 21712546 | |
| 331 | Phosphorylation | MQVIEQETPVSAKSS CEEEEECCCCCCCCC | 28.78 | 28450419 | |
| 334 | Phosphorylation | IEQETPVSAKSSRSQ EEECCCCCCCCCHHH | 31.05 | 25159151 | |
| 336 | Acetylation | QETPVSAKSSRSQLD ECCCCCCCCCHHHHH | 41.27 | 25953088 | |
| 336 | Ubiquitination | QETPVSAKSSRSQLD ECCCCCCCCCHHHHH | 41.27 | - | |
| 337 | Phosphorylation | ETPVSAKSSRSQLDL CCCCCCCCCHHHHHC | 30.60 | 23401153 | |
| 338 | Phosphorylation | TPVSAKSSRSQLDLF CCCCCCCCHHHHHCC | 34.93 | 25159151 | |
| 340 | Phosphorylation | VSAKSSRSQLDLFDD CCCCCCHHHHHCCCC | 36.72 | 25159151 | |
| 350 | Phosphorylation | DLFDDVGTFASGPPK HCCCCCCCCCCCCCC | 18.84 | 23403867 | |
| 353 | Phosphorylation | DDVGTFASGPPKYKD CCCCCCCCCCCCCCC | 47.87 | 23186163 | |
| 357 | Ubiquitination | TFASGPPKYKDNPFS CCCCCCCCCCCCCCC | 68.98 | - | |
| 358 | Phosphorylation | FASGPPKYKDNPFSL CCCCCCCCCCCCCCC | 29.37 | 24702127 | |
| 359 | Ubiquitination | ASGPPKYKDNPFSLG CCCCCCCCCCCCCCC | 58.09 | - | |
| 364 | Phosphorylation | KYKDNPFSLGESFGS CCCCCCCCCCCCCCC | 36.40 | 23927012 | |
| 368 | Phosphorylation | NPFSLGESFGSRWDT CCCCCCCCCCCCCCC | 32.86 | 22167270 | |
| 371 | Phosphorylation | SLGESFGSRWDTDAA CCCCCCCCCCCCCCC | 28.34 | 22167270 | |
| 387 | Ubiquitination | GMDRVEEKEPEVTIS CCCCCCCCCCCEEEE | 66.13 | - | |
| 392 | Phosphorylation | EEKEPEVTISSIRPI CCCCCCEEEEECCCC | 17.30 | 23312004 | |
| 394 | Phosphorylation | KEPEVTISSIRPISE CCCCEEEEECCCCCH | 15.45 | 24719451 | |
| 395 | Phosphorylation | EPEVTISSIRPISER CCCEEEEECCCCCHH | 20.83 | 25954137 | |
| 400 | Phosphorylation | ISSIRPISERATNRR EEECCCCCHHHCCHH | 24.58 | 25159151 | |
| 404 | Phosphorylation | RPISERATNRREVES CCCCHHHCCHHHHHH | 35.16 | 24719451 | |
| 413 | Phosphorylation | RREVESRSSGLESSE HHHHHHHHCCCCCHH | 37.73 | 29507054 | |
| 414 | Phosphorylation | REVESRSSGLESSEA HHHHHHHCCCCCHHH | 46.41 | 25159151 | |
| 418 | Phosphorylation | SRSSGLESSEARQKF HHHCCCCCHHHHHHH | 38.22 | 25159151 | |
| 419 | Phosphorylation | RSSGLESSEARQKFA HHCCCCCHHHHHHHC | 26.37 | 21815630 | |
| 429 | Acetylation | RQKFAGAKAISSDMF HHHHCCCCHHCCCCC | 45.39 | 25953088 | |
| 429 | Ubiquitination | RQKFAGAKAISSDMF HHHHCCCCHHCCCCC | 45.39 | 21890473 | |
| 432 | Phosphorylation | FAGAKAISSDMFFGR HCCCCHHCCCCCCCC | 25.74 | 29255136 | |
| 433 | Phosphorylation | AGAKAISSDMFFGRE CCCCHHCCCCCCCCC | 27.29 | 30266825 | |
| 435 | Sulfoxidation | AKAISSDMFFGREVD CCHHCCCCCCCCCCC | 3.03 | 21406390 | |
| 445 | Phosphorylation | GREVDAEYEARSRLQ CCCCCHHHHHHHHHH | 19.33 | 20007894 | |
| 458 | Phosphorylation | LQQLSGSSAISSSDL HHHHHCCCCCCHHHC | 32.90 | 28348404 | |
| 461 | Phosphorylation | LSGSSAISSSDLFGD HHCCCCCCHHHCCCC | 24.41 | 28348404 | |
| 462 | Phosphorylation | SGSSAISSSDLFGDM HCCCCCCHHHCCCCC | 23.04 | 28348404 | |
| 463 | Phosphorylation | GSSAISSSDLFGDMD CCCCCCHHHCCCCCC | 31.38 | 28348404 | |
| 477 | Phosphorylation | DGAHGAGSVSLGNVL CCCCCCCCCCCCCCC | 14.17 | 28348404 | |
| 479 | Phosphorylation | AHGAGSVSLGNVLPT CCCCCCCCCCCCCCC | 32.05 | 28348404 | |
| 498 | Phosphorylation | QFKQGVKSVAGKMAV HHHHHHHHHHHHHHH | 18.13 | 22817900 | |
| 513 | Phosphorylation | LANGVMNSLQDRYGS HHHHHHHHHHHHHCC | 14.87 | 14702039 | |
| 520 | Phosphorylation | SLQDRYGSY------ HHHHHHCCC------ | 20.80 | 22199227 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ARFG2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ARFG2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ARFG2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| MTND_HUMAN | ADI1 | physical | 26344197 | |
| ARFG1_HUMAN | ARFGAP1 | physical | 26344197 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-368 ANDSER-432, AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-432, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146; SER-368 ANDSER-432, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146 AND SER-368, ANDMASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-146 AND SER-498, ANDMASS SPECTROMETRY. | |